Marchex (FRA:NHM) 3-Year EBITDA Growth Rate: 25.30% (As of Jun. 2026) — 104% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NHM Marchex Inc FRA:NHM
57 GF Score
Price €1.52
GF Value €1.36
! 6 Warning Signs
View Full Analysis

What is Marchex 3-Year EBITDA Growth Rate?

Marchex FRA:NHM -0.65% 57 3-Year EBITDA Growth Rate is 25.30% as of Jun. 2026, which is 104% above its 10-year median of 12.40. GuruFocus rates FRA:NHM with a GF Score™ of 57/100 and a GF Value™ of €1.36. The stock has 6 warning signs investors should review. Among 756 Media - Diversified companies, Marchex ranks better than 77.25% on this metric.

Marchex's EBITDA per Share for the three months ended in Jun. 2026 was €-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Marchex was 781.90% per year. The lowest was -112.50% per year. And the median was 12.40% per year.


Marchex  (FRA:NHM) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Marchex 3-Year EBITDA Growth Rate Related Terms


FRA:NHM vs HFUS, TC, FLNT: 3-Year EBITDA Growth Rate Comparison

For the Advertising Agencies subindustry, Marchex's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marchex 3-Year EBITDA Growth Rate vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Marchex's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Marchex's 3-Year EBITDA Growth Rate falls into.


FRA:NHM
57GF Score
Marchex Inc FRA:NHM
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marchex 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 25.30% mean?
Marchex (FRA:NHM) has a 3-Year EBITDA Growth Rate of 25.30% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Marchex and its competitors. This is 104% above median its historical median of 12.40. According to the industry distribution chart, Marchex ranks #172 out of 756 companies in the Media - Diversified industry, placing it in the top 22.8%.
Is Marchex's 3-Year EBITDA Growth Rate too high?
Marchex's current 3-Year EBITDA Growth Rate of 25.30% is 104% above median its 10-year median of 12.40. The Media - Diversified industry median 3-Year EBITDA Growth Rate is 2.95. Marchex's value of 25.30% is 757.6% above this industry median. Based on the distribution chart, Marchex ranks #172 out of 756 companies in the Media - Diversified industry, which is in the top quartile — a strong position relative to peers. Overall, Marchex has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Marchex's 3-Year EBITDA Growth Rate compare to HFUS and TC?
According to the Media - Diversified industry distribution chart, Marchex ranks #172 out of 756 companies for 3-Year EBITDA Growth Rate. This places Marchex in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 2.95. Marchex's value of 25.30% is 757.6% above this benchmark. While the company's 10-year median is 12.40 vs. the industry median of 2.95, Marchex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Media - Diversified company?
The median 3-Year EBITDA Growth Rate among Media - Diversified companies is 2.95, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Marchex's current 3-Year EBITDA Growth Rate of 25.30% is 757.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Marchex and its competitors. For the Media - Diversified industry, the median 3-Year EBITDA Growth Rate is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marchex's current 3-Year EBITDA Growth Rate is 25.30%, which is 104% above median its own 10-year median of 12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marchex stock overvalued right now?
Marchex (FRA:NHM) has a current 3-Year EBITDA Growth Rate of 25.30%. The stock's GF Value™ is €1.36, compared to a current price of €1.52 — trading 11.8% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 25.30%, which is 104% above median its 10-year median of 12.40 and 757.6% above the Media - Diversified industry median of 2.95. Marchex's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Marchex (FRA:NHM), the current 3-Year EBITDA Growth Rate is 25.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Marchex (FRA:NHM) Overvalued in 2026?

Based on GuruFocus' analysis, Marchex stock appears to be overvalued. The current stock price of €1.52 is trading 11.8% above its estimated GF Value™ of €1.36.

Key valuation signals for FRA:NHM:

  • 3-Year EBITDA Growth Rate: 25.30% (104% above median its 10-year median of 12.40)
  • GF Value™: €1.36 vs. price of €1.52 (11.8% above fair value)
  • GF Score™: 57/100 with 6 warning signs
  • Industry Position: 757.6% above the Media - Diversified median (#172 of 756)

No single metric tells the full story. See the FRA:NHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Marchex Business Description

Other Exchanges MCHX:USA
Address 1200 5th Avenue, Suite 1300, Seattle, WA, USA, 98101
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
57GF Score

Get the complete analysis for FRA:NHM

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.52
Price
€1.36
GF Value